Scienture Inc. (SCNX)
NASDAQ: SCNX
· Real-Time Price · USD
1.05
-0.02 (-1.82%)
At close: Jun 16, 2025, 3:59 PM
-1.82% (1D)
| Bid | 1.03 |
| Market Cap | 13.77M |
| Revenue (ttm) | 136.64K |
| Net Income (ttm) | 9.07M |
| EPS (ttm) | 0.66 |
| PE Ratio (ttm) | 1.59 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.11 |
| Volume | 138,952 |
| Avg. Volume (20D) | 1,958,161 |
| Open | 1.06 |
| Previous Close | 1.07 |
| Day's Range | 1.02 - 1.08 |
| 52-Week Range | 0.69 - 23.77 |
| Beta | 2.74 |
About SCNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCNX
Website n/a
2 months ago
+19.5%
Scienture Holdings shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+9.55%
Scienture shares are trading higher after the company partnered with Kindeva to launch the 10mg REZENOPY nasal spray for opioid overdose treatment.